Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PHLT - US71377E1055 - Common Stock

7.75 USD
+0.02 (+0.26%)
Last: 10/20/2025, 8:10:13 PM
7.75 USD
0 (0%)
After Hours: 10/20/2025, 8:10:13 PM
Fundamental Rating

3

PHLT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. While PHLT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PHLT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PHLT has reported negative net income.
In the past year PHLT had a positive cash flow from operations.
PHLT had negative earnings in each of the past 5 years.
PHLT had a positive operating cash flow in 4 of the past 5 years.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.80%, PHLT is in line with its industry, outperforming 44.55% of the companies in the same industry.
PHLT has a Return On Equity (-1.08%) which is comparable to the rest of the industry.
PHLT has a worse Return On Invested Capital (0.19%) than 60.40% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROIC 0.19%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

PHLT has a worse Operating Margin (0.16%) than 60.40% of its industry peers.
PHLT does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHLT is destroying value.
PHLT has more shares outstanding than it did 1 year ago.
PHLT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHLT has a worse debt to assets ratio.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 13.67 indicates that PHLT is not in any danger for bankruptcy at the moment.
PHLT has a better Altman-Z score (13.67) than 95.05% of its industry peers.
PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
PHLT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. PHLT outperforms 77.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 13.67
ROIC/WACC0.02
WACC9.27%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

PHLT has a Current Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.64, PHLT belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
PHLT has a Quick Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.64, PHLT belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PHLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.50%, which is quite impressive.
Looking at the last year, PHLT shows a quite strong growth in Revenue. The Revenue has grown by 15.21% in the last year.
Measured over the past years, PHLT shows a decrease in Revenue. The Revenue has been decreasing by -3.95% on average per year.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%

3.2 Future

Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 50.55% on average per year.
Based on estimates for the next years, PHLT will show a quite strong growth in Revenue. The Revenue will grow by 11.37% on average per year.
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 103.61, the valuation of PHLT can be described as expensive.
60.40% of the companies in the same industry are cheaper than PHLT, based on the Price/Forward Earnings ratio.
PHLT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 103.61
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

62.38% of the companies in the same industry are cheaper than PHLT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 96.91
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHLT's earnings are expected to grow with 50.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.48%
EPS Next 3Y50.55%

More info and screens

0

5. Dividend

5.1 Amount

PHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (10/20/2025, 8:10:13 PM)

After market: 7.75 0 (0%)

7.75

+0.02 (+0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners88.43%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap623.41M
Revenue(TTM)137.36M
Net Income(TTM)-885.00K
Analysts48.89
Price Target7.91 (2.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-300.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-188.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.61
P/S 4.54
P/FCF N/A
P/OCF 129.71
P/B 7.58
P/tB 17.88
EV/EBITDA 96.91
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.77%
SpS1.71
BVpS1.02
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROCE 0.24%
ROIC 0.19%
ROICexc 0.21%
ROICexgc 0.48%
OM 0.16%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr 84.63%
Cap/Sales 3.82%
Interest Coverage 0.27
Cash Conversion 74.84%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 13.67
F-Score6
WACC9.27%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.29%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A

PERFORMANT HEALTHCARE INC / PHLT FAQ

What is the ChartMill fundamental rating of PERFORMANT HEALTHCARE INC (PHLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHLT.


What is the valuation status of PERFORMANT HEALTHCARE INC (PHLT) stock?

ChartMill assigns a valuation rating of 1 / 10 to PERFORMANT HEALTHCARE INC (PHLT). This can be considered as Overvalued.


How profitable is PERFORMANT HEALTHCARE INC (PHLT) stock?

PERFORMANT HEALTHCARE INC (PHLT) has a profitability rating of 1 / 10.


Can you provide the financial health for PHLT stock?

The financial health rating of PERFORMANT HEALTHCARE INC (PHLT) is 6 / 10.


What is the expected EPS growth for PERFORMANT HEALTHCARE INC (PHLT) stock?

The Earnings per Share (EPS) of PERFORMANT HEALTHCARE INC (PHLT) is expected to grow by 89.54% in the next year.